Brief: Diagonal Bio Q2 Operating Loss Widens To SEK 3.1 Mln
Aug 22 (Reuters) - Diagonal Bio AB DIABIO.ST :
* Q2 NET SALES SEK 0 MILLION VERSUS SEK 0 MILLION YEAR AGO
* Q2 OPERATING LOSS SEK 3.1 MILLION VERSUS LOSS SEK 2.8
MILLION
YEAR AGO
Source text for Eikon: ID:nWkrsc591
Further company coverage: DIABIO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Diagonal Bio AB
See all newsBrief: Diagonal Bio Approved For Delisting From Nasdaq First NGM
Brief: Diagonal Bio Gets Conditional Approval For Listing On NGM Nordic SME
Brief: Diagonal Bio Applies For Change Of Marketplace To NGM Nordic SME
Brief: Diagonal Bio Resolves On Directed Issue Of Units To All External Underwriters
Brief: Diagonal Bio Says Positive Pilot Test Results, Gets Order From Stallzet